Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID Reference, 4th edition, 372 pages

+ the daily Top 10


  Parkinson's Disease

  Free Subscription


Articles published in Proc Natl Acad Sci U S A

Retrieve available abstracts of 53 articles:
HTML format



Single Articles


    May 2020
  1. CAO M, Park D, Wu Y, De Camilli P, et al
    Absence of Sac2/INPP5F enhances the phenotype of a Parkinson's disease mutation of synaptojanin 1.
    Proc Natl Acad Sci U S A. 2020 May 18. pii: 2004335117.
    PubMed     Abstract available


    April 2020
  2. ZHANG DF, Wang D, Li YY, Yao YG, et al
    Is there an antagonistic pleiotropic effect of a LRRK2 mutation on leprosy and Parkinson's disease?
    Proc Natl Acad Sci U S A. 2020 Apr 28. pii: 2000533117.
    PubMed    


  3. LUAN Y, Tang D, Wu H, Gu W, et al
    Reversal of hyperactive subthalamic circuits differentially mitigates pain hypersensitivity phenotypes in parkinsonian mice.
    Proc Natl Acad Sci U S A. 2020 Apr 20. pii: 1916263117.
    PubMed     Abstract available


    March 2020

  4. Correction for Cristopher Bragg et al., Disease onset in X-linked dystonia-parkinsonism correlates with expansion of a hexameric repeat within an SVA retrotransposon in TAF1.
    Proc Natl Acad Sci U S A. 2020 Mar 9. pii: 2003190117.
    PubMed    


  5. MAHUL-MELLIER AL, Burtscher J, Maharjan N, Weerens L, et al
    The process of Lewy body formation, rather than simply alpha-synuclein fibrillization, is one of the major drivers of neurodegeneration.
    Proc Natl Acad Sci U S A. 2020;117:4971-4982.
    PubMed     Abstract available


    February 2020
  6. BOYER DR, Li B, Sun C, Fan W, et al
    The alpha-synuclein hereditary mutation E46K unlocks a more stable, pathogenic fibril structure.
    Proc Natl Acad Sci U S A. 2020;117:3592-3602.
    PubMed     Abstract available


    January 2020
  7. EARLS RH, Menees KB, Chung J, Gutekunst CA, et al
    NK cells clear alpha-synuclein and the depletion of NK cells exacerbates synuclein pathology in a mouse model of alpha-synucleinopathy.
    Proc Natl Acad Sci U S A. 2020;117:1762-1771.
    PubMed     Abstract available


    December 2019
  8. VITEK JL, Johnson LA
    Understanding Parkinson's disease and deep brain stimulation: Role of monkey models.
    Proc Natl Acad Sci U S A. 2019 Dec 23. pii: 1902300116.
    PubMed     Abstract available


    November 2019
  9. AGGARWAL A, Reichert H, VijayRaghavan K
    A locomotor assay reveals deficits in heterozygous Parkinson's disease model and proprioceptive mutants in adult Drosophila.
    Proc Natl Acad Sci U S A. 2019 Nov 20. pii: 1807456116.
    PubMed     Abstract available


  10. CHOPEK JW, Hultborn H, Brownstone RM
    Multistable properties of human subthalamic nucleus neurons in Parkinson's disease.
    Proc Natl Acad Sci U S A. 2019 Nov 11. pii: 1912128116.
    PubMed     Abstract available


    September 2019
  11. MORI A, Hatano T, Inoshita T, Shiba-Fukushima K, et al
    Parkinson's disease-associated iPLA2-VIA/PLA2G6 regulates neuronal functions and alpha-synuclein stability through membrane remodeling.
    Proc Natl Acad Sci U S A. 2019 Sep 23. pii: 1902958116.
    PubMed     Abstract available


    August 2019
  12. BECK G, Singh A, Zhang J, Potts LF, et al
    Role of striatal DeltaFosB in l-Dopa-induced dyskinesias of parkinsonian nonhuman primates.
    Proc Natl Acad Sci U S A. 2019 Aug 27. pii: 1907810116.
    PubMed     Abstract available


  13. ARAKI K, Yagi N, Aoyama K, Choong CJ, et al
    Parkinson's disease is a type of amyloidosis featuring accumulation of amyloid fibrils of alpha-synuclein.
    Proc Natl Acad Sci U S A. 2019 Aug 19. pii: 1906124116.
    PubMed     Abstract available


  14. DOCTROW B
    Profile of Claire L. Parkinson.
    Proc Natl Acad Sci U S A. 2019 Aug 5. pii: 1912448116.
    PubMed    


  15. LEE J, Pinares-Garcia P, Loke H, Ham S, et al
    Sex-specific neuroprotection by inhibition of the Y-chromosome gene, SRY, in experimental Parkinson's disease.
    Proc Natl Acad Sci U S A. 2019 Aug 1. pii: 1900406116.
    PubMed     Abstract available


    July 2019
  16. CAGNAN H, Mallet N, Moll CKE, Gulberti A, et al
    Temporal evolution of beta bursts in the parkinsonian cortical and basal ganglia network.
    Proc Natl Acad Sci U S A. 2019 Jul 24. pii: 1819975116.
    PubMed     Abstract available


  17. FAVA VM, Xu YZ, Lettre G, Van Thuc N, et al
    Pleiotropic effects for Parkin and LRRK2 in leprosy type-1 reactions and Parkinson's disease.
    Proc Natl Acad Sci U S A. 2019 Jul 15. pii: 1901805116.
    PubMed     Abstract available


  18. PASLAWSKI W, Zareba-Paslawska J, Zhang X, Holzl K, et al
    alpha-synuclein-lipoprotein interactions and elevated ApoE level in cerebrospinal fluid from Parkinson's disease patients.
    Proc Natl Acad Sci U S A. 2019 Jul 3. pii: 1821409116.
    PubMed     Abstract available


    June 2019
  19. CZANIECKI C, Ryan T, Stykel MG, Drolet J, et al
    Axonal pathology in hPSC-based models of Parkinson's disease results from loss of Nrf2 transcriptional activity at the Map1b gene locus.
    Proc Natl Acad Sci U S A. 2019 Jun 24. pii: 1900576116.
    PubMed     Abstract available


    March 2019
  20. HOLLENBACH JA, Norman PJ, Creary LE, Damotte V, et al
    A specific amino acid motif of HLA-DRB1 mediates risk and interacts with smoking history in Parkinson's disease.
    Proc Natl Acad Sci U S A. 2019 Mar 25. pii: 1821778116.
    PubMed     Abstract available


  21. SHEN HH
    Core Concept: Can deep brain stimulation find success beyond Parkinson's disease?
    Proc Natl Acad Sci U S A. 2019;116:4764-4766.
    PubMed    


  22. CHEN X, Kordich JK, Williams ET, Levine N, et al
    Parkinson's disease-linked D620N VPS35 knockin mice manifest tau neuropathology and dopaminergic neurodegeneration.
    Proc Natl Acad Sci U S A. 2019 Mar 6. pii: 1814909116.
    PubMed     Abstract available


    January 2019
  23. ZHANG P, Fan Y, Ru H, Wang L, et al
    Crystal structure of the WD40 domain dimer of LRRK2.
    Proc Natl Acad Sci U S A. 2019;116:1579-1584.
    PubMed     Abstract available


  24. LEVINE PM, Galesic A, Balana AT, Mahul-Mellier AL, et al
    alpha-Synuclein O-GlcNAcylation alters aggregation and toxicity, revealing certain residues as potential inhibitors of Parkinson's disease.
    Proc Natl Acad Sci U S A. 2019 Jan 16. pii: 1808845116.
    PubMed     Abstract available


    December 2018
  25. YAN R, Zhang J, Park HJ, Park ES, et al
    Synergistic neuroprotection by coffee components eicosanoyl-5-hydroxytryptamide and caffeine in models of Parkinson's disease and DLB.
    Proc Natl Acad Sci U S A. 2018 Dec 3. pii: 1813365115.
    PubMed     Abstract available


    November 2018
  26. BRESKA A, Ivry RB
    Double dissociation of single-interval and rhythmic temporal prediction in cerebellar degeneration and Parkinson's disease.
    Proc Natl Acad Sci U S A. 2018 Nov 13. pii: 1810596115.
    PubMed     Abstract available


    October 2018
  27. GUO JF, Zhang L, Li K, Mei JP, et al
    Coding mutations in NUS1 contribute to Parkinson's disease.
    Proc Natl Acad Sci U S A. 2018 Oct 22. pii: 1809969115.
    PubMed     Abstract available


  28. PUJOLS J, Pena-Diaz S, Lazaro DF, Peccati F, et al
    Small molecule inhibits alpha-synuclein aggregation, disrupts amyloid fibrils, and prevents degeneration of dopaminergic neurons.
    Proc Natl Acad Sci U S A. 2018;115:10481-10486.
    PubMed     Abstract available


    September 2018
  29. LEE KS, Huh S, Lee S, Wu Z, et al
    Altered ER-mitochondria contact impacts mitochondria calcium homeostasis and contributes to neurodegeneration in vivo in disease models.
    Proc Natl Acad Sci U S A. 2018;115:E8844-E8853.
    PubMed     Abstract available


    August 2018
  30. TELKES I, Viswanathan A, Jimenez-Shahed J, Abosch A, et al
    Local field potentials of subthalamic nucleus contain electrophysiological footprints of motor subtypes of Parkinson's disease.
    Proc Natl Acad Sci U S A. 2018 Aug 21. pii: 1810589115.
    PubMed     Abstract available


    July 2018
  31. RUGGERI FS, Benedetti F, Knowles TPJ, Lashuel HA, et al
    Identification and nanomechanical characterization of the fundamental single-strand protofilaments of amyloid alpha-synuclein fibrils.
    Proc Natl Acad Sci U S A. 2018;115:7230-7235.
    PubMed     Abstract available


    May 2018
  32. BORLONGAN CV
    Fatty acid chemical mediator provides insights into the pathology and treatment of Parkinson's disease.
    Proc Natl Acad Sci U S A. 2018 May 30. pii: 1807276115.
    PubMed    


  33. KIM KS, Marcogliese PC, Yang J, Callaghan SM, et al
    Regulation of myeloid cell phagocytosis by LRRK2 via WAVE2 complex stabilization is altered in Parkinson's disease.
    Proc Natl Acad Sci U S A. 2018 May 14. pii: 1718946115.
    PubMed     Abstract available


  34. NGUYEN M, Krainc D
    LRRK2 phosphorylation of auxilin mediates synaptic defects in dopaminergic neurons from patients with Parkinson's disease.
    Proc Natl Acad Sci U S A. 2018 May 7. pii: 1717590115.
    PubMed     Abstract available


  35. REN Q, Ma M, Yang J, Nonaka R, et al
    Soluble epoxide hydrolase plays a key role in the pathogenesis of Parkinson's disease.
    Proc Natl Acad Sci U S A. 2018 May 7. pii: 1802179115.
    PubMed     Abstract available


    March 2018
  36. KUMAR J, Erana H, Lopez-Martinez E, Claes N, et al
    Detection of amyloid fibrils in Parkinson's disease using plasmonic chirality.
    Proc Natl Acad Sci U S A. 2018 Mar 12. pii: 1721690115.
    PubMed     Abstract available


    February 2018
  37. GRASSI D, Howard S, Zhou M, Diaz-Perez N, et al
    Identification of a highly neurotoxic alpha-synuclein species inducing mitochondrial damage and mitophagy in Parkinson's disease.
    Proc Natl Acad Sci U S A. 2018 Feb 27. pii: 1713849115.
    PubMed     Abstract available


    January 2018
  38. KIM S, Yun SP, Lee S, Umanah GE, et al
    GBA1 deficiency negatively affects physiological alpha-synuclein tetramers and related multimers.
    Proc Natl Acad Sci U S A. 2018;115:798-803.
    PubMed     Abstract available


    December 2017
  39. WOERMAN AL, Kazmi SA, Patel S, Aoyagi A, et al
    Familial Parkinson's point mutation abolishes multiple system atrophy prion replication.
    Proc Natl Acad Sci U S A. 2017 Dec 26. pii: 1719369115.
    PubMed     Abstract available


  40. BRAGG DC, Mangkalaphiban K, Vaine CA, Kulkarni NJ, et al
    Disease onset in X-linked dystonia-parkinsonism correlates with expansion of a hexameric repeat within an SVA retrotransposon in TAF1.
    Proc Natl Acad Sci U S A. 2017 Dec 11. pii: 1712526114.
    PubMed     Abstract available


    September 2017
  41. KANG SS, Zhang Z, Liu X, Manfredsson FP, et al
    TrkB neurotrophic activities are blocked by alpha-synuclein, triggering dopaminergic cell death in Parkinson's disease.
    Proc Natl Acad Sci U S A. 2017 Sep 18. pii: 201713969.
    PubMed     Abstract available


  42. THAKUR P, Breger LS, Lundblad M, Wan OW, et al
    Modeling Parkinson's disease pathology by combination of fibril seeds and alpha-synuclein overexpression in the rat brain.
    Proc Natl Acad Sci U S A. 2017 Sep 12. pii: 201710442.
    PubMed     Abstract available


    June 2017
  43. TURRIANI E, Lazaro DF, Ryazanov S, Leonov A, et al
    Treatment with diphenyl-pyrazole compound anle138b/c reveals that alpha-synuclein protects melanoma cells from autophagic cell death.
    Proc Natl Acad Sci U S A. 2017 Jun 5. pii: 201700200.
    PubMed     Abstract available


    April 2017
  44. KOUROUPI G, Taoufik E, Vlachos IS, Tsioras K, et al
    Defective synaptic connectivity and axonal neuropathology in a human iPSC-based model of familial Parkinson's disease.
    Proc Natl Acad Sci U S A. 2017 Apr 17. pii: 201617259.
    PubMed     Abstract available



  45. Editorial Expression of Concern: Parkin, a gene implicated in autosomal recessive juvenile parkinsonism, is a candidate tumor suppressor gene on chromosome 6q25-q27.
    Proc Natl Acad Sci U S A. 2017 Apr 3. pii: 201704295.
    PubMed    


    March 2017
  46. KIM KS
    Toward neuroprotective treatments of Parkinson's disease.
    Proc Natl Acad Sci U S A. 2017 Mar 30. pii: 201703362.
    PubMed    


  47. SPATHIS AD, Asvos X, Ziavra D, Karampelas T, et al
    Nurr1:RXRalpha heterodimer activation as monotherapy for Parkinson's disease.
    Proc Natl Acad Sci U S A. 2017 Mar 27. pii: 201616874.
    PubMed     Abstract available


  48. MOLLENHAUER B, Weintraub D
    The depressed brain in Parkinson's disease: Implications for an inflammatory biomarker.
    Proc Natl Acad Sci U S A. 2017 Mar 10. pii: 201700737.
    PubMed    


    February 2017
  49. DUNN AR, Stout KA, Ozawa M, Lohr KM, et al
    Synaptic vesicle glycoprotein 2C (SV2C) modulates dopamine release and is disrupted in Parkinson disease.
    Proc Natl Acad Sci U S A. 2017 Feb 28. pii: 201616892.
    PubMed     Abstract available


    January 2017
  50. GREEN H, Zhang X, Tiklova K, Volakakis N, et al
    Alterations of p11 in brain tissue and peripheral blood leukocytes in Parkinson's disease.
    Proc Natl Acad Sci U S A. 2017 Jan 30. pii: 201621218.
    PubMed     Abstract available


  51. PARK Y, Hoang QQ
    Combating Parkinson's disease-associated toxicity by modulating proteostasis.
    Proc Natl Acad Sci U S A. 2017 Jan 17. pii: 201620082.
    PubMed    


    October 2016
  52. HORVATH I, Wittung-Stafshede P
    Cross-talk between amyloidogenic proteins in type-2 diabetes and Parkinson's disease.
    Proc Natl Acad Sci U S A. 2016 Oct 17. pii: 201610371.
    PubMed     Abstract available


    April 2016
  53. PINOTSI D, Michel CH, Buell AK, Laine RF, et al
    Nanoscopic insights into seeding mechanisms and toxicity of alpha-synuclein species in neurons.
    Proc Natl Acad Sci U S A. 2016;113:3815-9.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Parkinson's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: